REDCARE PHARMACY INH.REDCARE PHARMACY INH.REDCARE PHARMACY INH.

REDCARE PHARMACY INH.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.63 B‬EUR
‪−12.04 M‬EUR
‪1.80 B‬EUR
‪13.27 M‬
Beta (1Y)
0.11

About REDCARE PHARMACY N.V.

CEO
Olaf Heinrich
Headquarters
Sevenum
Employees (FY)
‪2.08 K‬
Founded
2001
ISIN
NL0012044747
FIGI
BBG00DSX0K76
Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. It operates under the DACH and International segments. The DACH segment includes medications and pharmacy-related BPC products sold to customers in Germany, Austria, and Switzerland. The International segment focuses on Belgium, the Netherlands, France, and Italy. The company was founded by Frank Köhler, Stephan Weber, and Marc Fischer in January 2001 and is headquartered in Sevenum, the Netherlands.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RDC is 132.8 EUR — it has increased by 2.39% in the past 24 hours. Watch REDCARE PHARMACY INH. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange REDCARE PHARMACY INH. stocks are traded under the ticker RDC.
REDCARE PHARMACY INH. is going to release the next earnings report on Jul 30, 2024. Keep track of upcoming events with our Earnings Calendar.
RDC stock is 3.19% volatile and has beta coefficient of 0.11. Track REDCARE PHARMACY INH. stock price on the chart and check out the list of the most volatile stocks — is REDCARE PHARMACY INH. there?
Yes, you can track REDCARE PHARMACY INH. financials in yearly and quarterly reports right on TradingView.
RDC stock has risen by 2.08% compared to the previous week, the month change is a 9.84% fall, over the last year REDCARE PHARMACY INH. has showed a 47.69% increase.
RDC net income for the last quarter is ‪−7.81 M‬ EUR, while the quarter before that showed ‪−5.58 M‬ EUR of net income which accounts for −39.85% change. Track more REDCARE PHARMACY INH. financial stats to get the full picture.
Today REDCARE PHARMACY INH. has the market capitalization of ‪2.59 B‬, it has increased by 0.47% over the last week.
No, RDC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RDC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REDCARE PHARMACY INH. stock right from TradingView charts — choose your broker and connect to your account.
RDC reached its all-time high on Feb 16, 2021 with the price of 248.0 EUR, and its all-time low was 23.6 EUR and was reached on Dec 9, 2016. View more price dynamics on RDC chart.
See other stocks reaching their highest and lowest prices.
As of May 6, 2024, the company has ‪2.08 K‬ employees. See our rating of the largest employees — is REDCARE PHARMACY INH. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REDCARE PHARMACY INH. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REDCARE PHARMACY INH. stock shows the buy signal. See more of REDCARE PHARMACY INH. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on REDCARE PHARMACY INH. future price: according to them, RDC price has a max estimate of 190.00 EUR and a min estimate of 109.00 EUR. Watch RDC chart and read a more detailed REDCARE PHARMACY INH. stock forecast: see what analysts think of REDCARE PHARMACY INH. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REDCARE PHARMACY INH. EBITDA is ‪94.40 M‬ EUR, and current EBITDA margin is 2.25%. See more stats in REDCARE PHARMACY INH. financial statements.